Fig. 2: Neutralizing activities of MW05 and MW07. | Nature Communications

Fig. 2: Neutralizing activities of MW05 and MW07.

From: Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys

Fig. 2

a, b SARS-CoV-2 pseudovirus neutralizing activities of MW05 and MW07 were evaluated on Huh7 cells. Fifty percent neutralization titer (NT50) was calculated by fitting the luciferase activities from serially diluted antibodies to a sigmoidal dose–response curve. The average ± SD from two independent experiments with technical duplicates is shown. c, d SARS-CoV-2 authentic virus-neutralizing activities of MW05 and MW07 were evaluated using Vero E6 cells. One hundred percent neutralization titer (NT100) was labeled accordingly.

Back to article page